Ensuring the affordable becomes accessible–lessons from ketamine, a new treatment for severe depression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ensuring the affordable becomes accessible–lessons from ketamine, a new treatment for severe depression
Authors
Keywords
-
Journal
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
SAGE Publications
Online
2023-10-13
DOI
10.1177/00048674231203898
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
- (2023) Amit Anand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Must Psilocybin Always “Assist Psychotherapy”?
- (2023) Guy M. Goodwin et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial
- (2023) Colleen Loo et al. BRITISH JOURNAL OF PSYCHIATRY
- Can old drugs learn new tricks? Achieving registration and public subsidy listing for off‐patent medicines with novel therapeutic applications
- (2023) Jonathan Brett et al. INTERNAL MEDICINE JOURNAL
- Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
- (2022) Anees Bahji et al. Expert Opinion On Drug Safety
- Realising the potential: leveraging clinical quality registries for real world clinical research
- (2022) Susannah Ahern et al. MEDICAL JOURNAL OF AUSTRALIA
- Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials
- (2022) Jay J. H. Park et al. JAMA Network Open
- Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
- (2022) Olina Efthymiadou et al. BMC HEALTH SERVICES RESEARCH
- Effect of Cytisine vs Varenicline on Smoking Cessation
- (2021) Ryan J. Courtney et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Journal of Affective Disorders Dose Effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis
- (2021) Nan-Xi Li et al. JOURNAL OF AFFECTIVE DISORDERS
- Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses
- (2021) Tácio de Mendonça Lima et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis
- (2021) Kimberly W. Smith et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
- (2020) Anees Bahji et al. JOURNAL OF AFFECTIVE DISORDERS
- The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
- (2020) Elliot Marseille et al. PLoS One
- Psychiatric Practice Patterns and Barriers to the Adoption of Esketamine
- (2019) Samuel T. Wilkinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Cytisine for smoking cessation
- (2018) Taleen Karnieg et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Discovery and development of varenicline for smoking cessation
- (2018) Chloe J. Jordan et al. Expert Opinion on Drug Discovery
- New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics
- (2018) Sonya Das et al. JAMA Oncology
- CHARACTERISTICS OF MANAGED ENTRY AGREEMENTS IN AUSTRALIA
- (2017) Maxine F. Robinson et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- The Clinical Alliance and Research in Electroconvulsive Therapy Network
- (2017) Donel M. Martin et al. JOURNAL OF ECT
- Antibiotic development pipeline slows to a trickle
- (2017) Talha Burki LANCET INFECTIOUS DISEASES
- Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
- (2017) J. Javier Hernandez et al. Frontiers in Oncology
- Interdisciplinary research has consistently lower funding success
- (2016) Lindell Bromham et al. NATURE
- Quantifying the Magnitude and Cost of Collecting Extraneous Protocol Data
- (2015) Kenneth A. Getz et al. AMERICAN JOURNAL OF THERAPEUTICS
- Obstacles to Developing Cost-Lowering Health Technology
- (2015) Arthur L. Kellermann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Managed entry agreements for pharmaceuticals in Australia
- (2014) Agnes Vitry et al. HEALTH POLICY
- Increasing value and reducing waste in biomedical research regulation and management
- (2014) Rustam Al-Shahi Salman et al. LANCET
- Biomedical research: increasing value, reducing waste
- (2014) Malcolm R Macleod et al. LANCET
- Cytisine versus Nicotine for Smoking Cessation
- (2014) Natalie Walker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pilot dose–response trial of i.v. ketamine in treatment-resistant depression
- (2014) Rosalyn Lai et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Cytisine, the world's oldest smoking cessation aid
- (2013) J. J. Prochaska et al. BMJ-British Medical Journal
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- R&D Incentives for Neglected Diseases
- (2012) Nicola Dimitri PLoS One
- Funding Linked to Ongoing Research: Impact of the Bosentan Patient Registry on Pricing in Australia
- (2011) John Wlodarczyk et al. VALUE IN HEALTH
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- Glutamatergic Modulators: The Future of Treating Mood Disorders?
- (2010) Carlos Zarate et al. HARVARD REVIEW OF PSYCHIATRY
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started